おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Epic Sciences
company
About
Epic Sciences is a diagnostics company improving cancer management by providing real-time biopsy material to guide personalized medicine.
- 101 - 250
Details
- Last Funding Type
- Series F
- Last Funding Money Raised
- $43M
- Industries
- Biotechnology,Health Care,Health Diagnostics,Hospital
- Founded date
- Jan 1, 2008
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Epic Sciences is a privately held diagnostics company committed to improving cancer management by providing easily accessible and real-time biopsy material to guide personalized medicine. Epic is founded on a powerful platform to identify and characterize rare cells including circulating tumor cells ("CTCs"). Epic is working with a number of partners including numerous pharmaceutical companies, major cancer centers, the National Cancer Institute, and the National Institutes of Health.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$135M
Epic Sciences has raised a total of
$135M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2022 from a Series F round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2022 | Series F | $43M | 1 | — | — | Detail |
| Sep 12, 2018 | Series E | $52M | 1 | — | — | Detail |
| Apr 28, 2017 | Series D | $40M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Epic Sciences is funded by 2 investors.
LabCorp
and Altos Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
LabCorp
|
— | Series F |
|
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
